The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients
- 2 September 2020
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Precision Medicine and Drug Development
- Vol. 5 (5) , 313-316
Abstract
(2020). The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients. Expert Review of Precision Medicine and Drug Development. Ahead of Print.Keywords
This publication has 45 references indexed in Scilit:
- Impact of CYP3A4*22 Allele on Tacrolimus Pharmacokinetics in Early Period After Renal TransplantationTherapeutic Drug Monitoring, 2013
- A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipientsBritish Journal of Clinical Pharmacology, 2013
- Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF GenomicsTransplant International, 2013
- Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical TrialsAmerican Journal of Transplantation, 2013
- Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism – a prospective, randomized, controlled studyClinical Transplantation, 2013
- Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2012
- Dosing equation for tacrolimus using genetic variants and clinical factorsBritish Journal of Clinical Pharmacology, 2011
- Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective studyTransplant International, 2011
- Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant RecipientsTherapeutic Drug Monitoring, 2009
- The Influence of Pharmacogenetics on the Time to Achieve Target Tacrolimus Concentrations after Kidney TransplantationAmerican Journal of Transplantation, 2004